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Background: Hepatitis B Virus is a major public health problem worldwide. In 2012 alone, over 350 million chronic
carriers and 1. 2 million annual deaths were occurred. Hepatitis B Virus causes 60 to 80% of the world’s primary liver
cancer and nearly 90% infants infected due to vertical transmission are at higher risk of developing chronic liver
disease and cancer. Hence determining the burden of maternal and neonatal Hepatitis B Virus infection is a priority.
Methods: A cross sectional study was conducted from July – September 2012 at St. Paul’s Hospital Millennium
Medical College and Selam Health Center, Addis Ababa, Ethiopia. Blood samples from delivering mothers (n = 265)
and their corresponding cords (n = 265) were collected. A pretested questionnaire was used to collect data.
Hepatitis B Virus surface antigen was detected using Enzyme Linked Immunosorbent Assay. Frequency analysis and
logistic regression test was used to identify the potential risk factors associated with Hepatitis B Virus positivity
using SPSS Version −15.
Results: A total of 265 delivering women with the mean age of 25.8 years were enrolled in the study. Of these
delivering women, 8 (3.0%) of mothers were positive for Hepatitis B Virus surface antigen, whereas 6 (2.3%) of cord
bloods were positives with 75% concordance rate of exposed infants with sero-positive mothers. However, only
one maternal positive case was observed for Hepatitis B e Ag test. Only 11% of the mothers know their Hepatitis B
Virus status. Of the total mothers assessed for possible risk factors, 69 (26%) had only one type, while 161 (60.8%) had
multiple exposure factors such as ear pricing, history of tribal marks, abortion, multiple-sexual partner and history
of surgical procedures experienced from high to low frequency. The remaining 35 (13.2%) of the participants had
not experienced possible risk factors.
Conclusion: Though the maternal positivity rate was low, the rate of positivity in cord bloods was almost equal to
those infected mothers. Therefore, screening of pregnant mothers and vaccination of infants could help to reduce
the transmission. To minimize the higher overall risk exposure status of mothers, increasing awareness and
intensive public health education is also recommended.
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Hepatitis B virus (HBV) infection is one of the leading
causes of liver diseases causing serious public health
problem worldwide. It is 50 – 100 and 10 times more in-
fectious than human immune deficiency virus (HIV) and
hepatitis C virus (HCV), respectively. Many of the car-
riers are not realizing that they are infected with the
virus and thus HBV is referred as a “silent killer” [1].
The virus is found in all body fluids and therefore,
transmission could be either vertically (from infected
mother to the infant or to the child) or horizontally
(sexually and/or contact with different body fluids)
[2,3]. However, mother to child transmission (MTCT)
of HBV is of great importance for two main reasons as
it is numerically important mode of transmission and
the earlier an individual is infected the more likely to
develop chronic disease [4]. In highly endemic areas,
up to 75% of chronic carriers acquire the infection
through vertical transmission [5]. The transmission
and infection during infancy increases the chance to
develop chronic disease to 90%, while adults usually
acquire acute hepatitis B and recover, and hence the
chance is 6 to 10% only [6].
In most developing countries with high HBV preva-
lence, intrauterine/transplacental transmission can lead
to coagulation defects, postpartum hemorrhage, organ
failure, high maternal mortality and poor outcomes of
their newborns such as still births, neonatal deaths,
acute and chronic liver disease, hepatocellular carcinoma
and increased premature delivery [7].
According to recent WHO report, one- third of the
world’s populations have serologic evidence of past or
present HBV infection. Of these, about 350 million are
chronic carriers [8,9], and 1. 2 million die annually from
chronic hepatitis, cirrhosis and hepatocellular carcinoma
[10]. HBV causes 60 to 80% of the world’s primary liver
cancers [11]. The reported prevalence of chronic HBV
infection varies widely, from high (≥8%, in Africa, Asia,
and the Western Pacific countries) to intermediate (2-7% in
Southern and Eastern Europe), and low (<2%, in Western
Europe, North America and Australia) [12].
Studies conducted on the mechanism of intrauterine in-
fection of HBV in China showed 81.4% positivity rate of
hepatitis B surface antigen (HBsAg) in placentas from 59
HBsAg- positive mothers [13]. However, a study from
Nigeria showed 51.6% vertical transmission rate from
8.3% HBsAg positive mothers [14]. In Ethiopia, three stud-
ies [Jimma (South West), and DebreTabor and BahirDar
(North West)] showed a seroprevalence of 3.7%, 5.3% and
3.8%, among pregnant women, respectively [15-17].
In spite of this, routine antenatal screening for HBV
infection and vaccination is lacking in many Ethiopian
health facilities [16,18]. Moreover, no recent published
data is seen on the maternal and neonatal HBV infectionin Ethiopia generally and in Addis Ababa particularly.
Therefore, this study was aimed at finding out the burden
of HBV and asses possible risk factors among delivering
women and their new born in some selected health facil-
ities in Addis Ababa, Ethiopia.Methods
Study design, setting & study period
A cross sectional study was conducted from July-
September 2012 among consecutively recruited 265 deliver-
ing women and their respective infant cord samples from
two selected health facilities in Addis Ababa, Ethiopia [St.
Paul’s Hospital Millennium Medical College and Selam
Health Center]. Both health facilities give anti-natal care,
delivery, post-natal care, and any fetomaternal related ser-
vices including anti retro viral therapy (ART) within the fa-
cility and from referral cases. The monthly delivery rate of
the two facilities at the time of the study was, 150 and 40,
respectively.Population
All pregnant women who came for delivery during the
study period were used as source population. Those women
who were delivered during the study period at the two
study health facilities and fulfill the inclusion criteria were
considered as a study population.Sample size calculations and data collection
The sample size was calculated based on single sample
size estimation [19]. The prevalence rate (p) was taken
as 6.1% from a previous study conducted [20] with the
precision of 3.5%. From this, a sample size was calcu-
lated as 265 (including 10% non response rate) with 265
corresponding cord samples. Midwifes and nurses were
trained to collect data (using a pre-tested well structured
questionnaire). Five milliliters of whole blood samples
from mothers and the corresponding cords were col-
lected aseptically using ethylene diamine tetra-acetate
(EDTA) test tubes (BD, USA). Plasma samples were sep-
arated and stored in a refrigerator (−20 degrees) until
tested for HBsAg using Enzyme Immuno Sorbent Assay
(ELISA) [DIALAB, Germany] and for Hepatitis B e Ag
(HBeAg) [Insight HBeAg rapid test kit, [TULIP DIAG-
NOSTICS, Germany].Data analysis
The data were entered in to SPSS (version 15) and
double checked before analysis. Descriptive statistics
(means, percentages or frequency) were calculated and
the associations were assessed by using the logistic re-
gression. Significance associations were tested using a p-
value < 0.05.
Table 1 Socio- demographic characteristics of delivering
women at St Paul’s Hospital Millennium Medical College
and Selam health center Addis Ababa, Ethiopia
(July-September, 2012)
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Socio demographic characteristics of study participants
A total of 265 delivering women and their respective in-
fant cord blood samples were collected [221 (83%) from
St. Paul’s Hospital Millennium Medical College and 44
(17%) from Selam Health Center] in the period of July
2012 to September 2012. The mean age was 25.8 years
(Range: 15–40 years). Most of them (77%) were living in
Addis Ababa and 91.3% of them were married. Of all,
38% and 8.5% of them had a primary and tertiary educa-
tion, respectively (Table 1). Only 11% of the mothers
know about their HBV status in their anti-natal care








Others 2 0.75Maternal and neonatal cord blood Hepatitis B virus positivity
Of the total 265 study participants tested, 8 (3.0%) [95%
CI: 2.7 - 3.4] of mothers and 6 (2.3%) [(95% CI: 2.0 - 3.5]
of infant’s cord blood samples were positive for HBsAg
[2 infants per 100 mothers]. Of the infant cord blood
samples, 6 (75%) of them had similar results to their
infected mothers, while 2 (25%) of them had negative
results. From all samples tested for HBeAg, only
one case (12.5%) was positive. At least one HBsAg
positive result was observed in each age group and
in every education category. However, only house
wives and governmental employees had more HBsAg
positive results. Except the facility, where the partici-
pants are recruited, other socio demographic charac-
teristics were not significantly associated with HBV
positivity (p-value > 0.05).
Although no statistically significant difference among
the age groups, the highest and lowest prevalence was
observed in the age groups of 35–40 years (10%), and
25–29 years (1.9%), respectively (Table 2).
Despite small number of positive cases, HBV infection
showed a decrease trend with education [(1.5%) from
illiterates, 1.13% from primary, 0.38% from secondary
and (0.0%) from tertiary educated participants].Risk factors and HBV positivity
Among the possible risk factors for HBV infection
assessed, the highest possible risk factor was ear pricing
(69%) and the lowest was history of surgical procedures
(9%). The specific distribution of risk factors and their
association with the HBV positivity is given on Table 3.
Twenty (7.5%) of the total delivering women were HIV
positives, of whom 16 (80%) of them were on ART.
However, none of them were positive for HBV. Gener-
ally, in this study, 35 (13.2%) of the participants had no
any kind of possible risk factor for exposure. Only 26%
had one type of exposure and about 60.8% of the study
participants had multiple exposure history. However,
among those with multiple exposures, 4 of them were
Table 2 Maternal HBV status with demographic charactersticies at St Paul’s Hospital Millennium Medical College and
Selam Health Center Addis Ababa, Ethiopia (July-September, 2012)
Demographic characteristics HBV status of mothers Cr. OR Adj. OR
Positive Negative
N (%) N (%)
Address Addis Ababa 5 (1.9%) 199 (75.1%) 0.85 (0.35-11) 0.2 (0.5-1.2)
Out of Addis Ababa 3 (1.12%) 58 (21.88%) 1 1
Facility St PMMCH 8 (3.02%) 213 (80.37) 1.2 (1.1-13)* 1.7 (1.3-22)
SHE 0 (0%) 44 (16.6%) 1 1
Age group 15-19 1 (0.38%) 19 (7.2%) 2 (0.2-10) 8.3 (0.3-23)
20-24 2 (0.76%) 82 (30.9%) 4.6 (0.6-15) 12 (0.9-35)
25-29 2 (0.76%) 103 (38.9%) 5.7 (0.8-43) 9 (0.8-102)
30-34 1 (0.38%) 35 (13.2%) 4 (0.33-46) 7 (0.4-122)
35-40 2 (0.76%) 18 (6.8%) 1 1
Education Illiterate 4 (1.51%) 81 (30.55%) 3.5 (0.3-24) 6 (0.17-235)
Primary 3 (1.13%) 98 (37.0%) 1.7 (0.08-14) 4 (0.1-147)
Secondary 1 (0.38%) 56 (21.13%) 1.2 (0.2-11) 1.7 (0.03-73)
Tertiary 0 (0.0%) 22 (8.30%) 1 1
Monthly income (in Birr) <500 3 (1.13%) 88 (33.23%) 0.15 (0.6-8) 0.3 (0.04-3)
500-1000 2 (0.76%) 114 (43%) 20 0.2 (0.09-3) 0.4 (0.01-3.4)
1001-1500 2 (0.76%) (7.54%) 1.3 (0.56-7) 1.6 (0.14-18)
15.1-2000 0 (0.00%) 11 (4.15%) 0.13 (0.8-9) 0.2 (0.01-28)
> 2000 1 (0.38%) 24 (9.05%) 1 1
Marital status Married 7 (2.64%) 235 (88.7%) 1.65 (0.75-3) 3 (1–28)
Single 1 (0.38%) 22 (8.3%) 1
Adj. OR, Adjusted odds ratio; Cr. OR, Crude odds ratio; *p-value < 0.05; St. PMMCH, St. Paul’s Hospital Millennium Medical College; SHC, Selam Health Center; 1,
Reference value; N, Number.
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tors were significantly associated with the status of HBV
positivity (p-value >0.05), which might be due to small
number of HBV cases.
Discussion
HBV is the common cause of liver cancer worldwide
with 350 million chronic carriers and 1.2 million annual
deaths [8,10]. It is 50 – 100 and 10 times more infec-
tious than HIV and HCV, respectively [1]. Vertical trans-
mission from infected mothers to their infants occurs
through intrauterine transmission. This way is the major
source of infection in many endemic areas [21]. About
90% of the infected infants develop chronic carrier state
(of which 25% develop cancer) compared to adults with
below 10%.
Centers for Disease Control and Prevention (CDC)
recommended screening of all pregnant women for HBV
and provision of prophylaxis for those who are positives
[22]. If mothers are not screened at ANC and/or with
no documented results, the screening should be done on
delivering mothers as soon as possible; and vaccine to
be given for infants within 12 hours of delivery [23].Despite this, in this study, only 11% of the mothers
know their HBV status, which indicates the screening
should be strengthened in these health facilities during
their ANC follow-up.
In our study, the overall prevalence among delivering
women was 3.0% for HBsAg and only one case for
HBeAg. This makes the study sites as an intermediate
endemic area (2–7%) for HBV infection according to
WHO criteria [24,25]. Our finding is in agreement with
the previous reports of HBsAg infection rate among
pregnant women in Western (3.7%) and North Western
(3.8%) Ethiopia [15,17]. In contrast, lower prevalence
rates were observed from Saudi Arabia (1.6%) and Libya
(1.5%) [26,27]. Moreover, higher infection rates were also
observed in Sudan (5.6%), Yemen (10%) and Niger (5.6%)
[28-30]. Higher prevalence rates as high as 10% were re-
ported from India (10%), Nigeria (11%), Yemen (10%) and
Mali (8%) [14,30-32], respectively. The variations observed
compared to this study could be due to the methods used,
geographical variations, sample size and the study design.
Moreover, unlike ours, some reports such as from those
Asian countries (India and China) were from the highest
prevalence regions of WHO criteria [31]. However, those
Table 3 Association of possible potential risk factors and maternal HBV status at St Paul’s Hospital Millennium Medical
College and Selam health center Addis Ababa, Ethiopia (July 2012 - September 2012)
Risk factors HBsAg positive HBsAg –Ve. Cr. OR. Adj. OR.
N (%) N (%)
Dental procedure Yes: 2 (0.76%) 30 (11.32%) 0.4 (0.07 - 2.0) 2 (0.25-17)
No: 6 (2.26%) 227 (85.66%) 1.00 1
Surgical procedure Yes: 3 (1.14%) 21 (7.90%) 1.2 (0.03 - 1.7) 3.2 (0.56-18)
No: 5 (1.88%) 236 (89.0%) 1.00 1
Tattooing Yes: 4 (1.50%) 53 (20.0%) 0.26 (0.6 - 1.07) 1.2 (0.3-2.4)
No: 4 (1.50%) 204 (77.0%) 1.00 1
Abortion Yes: 2 (0.76%) 42 (15.84%) 0.6 (0.11 - 3.0) 1.6 (0.2-13)
No: 6 (2.26%) 215 (81.14%) 1.00 1
Ear piercing Yes: 6 (2.26%) 177 (66.8%) 0.74 (0.15 - 3.7) 0.6 (0.07-4)
No: 2 (0.76%) 80 (30.20%) 1.00 1
Blood received Yes: 2 (0.76%) 10 (3.77%) 1.1 (0.01- 1.2) 7 (0.8 - 69)
No: 6 (2.26%) 247 (93.2%) 1.00 1
Multigravida Yes: 4 (1.51%) 102 (38.5%) 0.67 (0.16 - 2.7) 1.05 (0.2-5.6)
No: 4 (1.51%) 155 (58.5%) 1.00 1
Multiple sexual partner Yes: 2 (0.76%) 37 (14.0%) 0.51 (0.1 - 2.6) 1.5 (0.2-10)
No: 6 (2.26%) 220 (83.0%) 1.00 1
Caesarian section Yes: 4 (1.51%) 62 (23.42%) 0.32 (0.08 - 1.3) 1.8 (0.36-9)
No: 4 (1.51%) 195 (73.56%) 1.00 1
P-val., P-value; Adj. OR, Adjusted odds ratio; Cr. OR, Crude odds ratio; −ve., Negative; HBsAg, Hepatitis B surface antigen; 1, Reference value; N, Number.
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prevalence (in 1988), which might be due to lower
awareness of the population towards HBV infection in
that period [16].
The assessed HBV infection in neonates, due to verti-
cal transmission (cord blood) with a prevalence of 2.3%
and 75% of concordant result with mother’s positivity
might directly showed the increased exposure of infants
from their mothers through intrauterine transmission.
This might lead to a higher chance (up to 90% chronic
carrier state) of increasing in the development of liver
cancer among these chronically infected children in their
lifetime. In contrast to our findings of higher concordance
with the infants, slightly lower rates of concordance were
reported from India 50% [31], Nigeria 51.6% [14], and Libya
(60.9%) [27]. These observed lower rates might be due to
effective ANC screening, use of vaccine and provision of
prophylaxis as the major prevention mechanisms, unlike
ours with a very low ANC screening coverage (11%).
In most epidemiological studies on HBV infection,
there has been a link between age and the acquisition of
HBsAg that indicates, age of acquiring of the infection
as one of the major determinant factor for HBsAg positivity
[27]. In our study, although not statistically significant,
higher prevalence (10%) and lower prevalence (1.9%) was
observed in the age groups of 35–40 and 25–29 years,
respectively. Similar findings were reported from SaudiArabia that showed an increase in prevalence with age and
higher prevalence with age groups greater than 25 years
compared to those less than 25 years [26].
Although level of education is known as the determinant
factor for HBV infection with a reverse pattern, which
might be due to the level of awareness, so many findings
like our finding showed no significant differences among
different study populations such as those from Nigeria
[14,32], Sudan [28], Mali [33] and Zimbabwe [34].
Some factors are known to be directly or indirectly
lead to exposure for HBV infection [14,15]. In our study,
from all delivering women, the highest percentage 183
(69%) of them had ear pricing history of whom 6 (2.3%))
were from HBsAg positives. Hundred and six (40%) of
them had multigravida, of whom 4 (1.5%) were HBsAg
positives. Similar distributions of risk factors were ob-
served from a study conducted in Western Ethiopia as
5.6% of them had dental procedures and 11.2% of them
with tattoos [15].
Conclusions
In conclusion, the prevalence of HBsAg among the de-
livering women in this study was 3.0%, which is an inter-
mediate prevalence according to the WHO criteria that
require routine screening and vaccination program. An
almost equal rate of positivity in cord blood to the in-
fected mothers (75%) revealed the need to have routine
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transmission of HBV as previous history of routine
ANC screening coverage was very low in these study
sites (11%). The overall exposure status of mothers for
possible risk factors was also high, which might also
requires creating awareness using media in general and
public health education in the health facilities in par-
ticular, as a priority prevention strategy.
However, due to a few number of HBsAg positive sam-
ples (both from the mothers and the cord bloods), con-
clusions from this study remains to be with caution.
Therefore, large sample size studies and assessments for
the neonatal transmission and possible risk factors in-
cluding maternal knowledge, attitude and practice are
also recommended.
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ELISA: Enzyme linked immuno sorbent assay; HBeAg: Hepatitis B e Antigen;
HBsAg: Hepatitis B surface Antigen; HBV: Hepatitis B virus; HCC: Hepatocellular
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